Delirium Reduction With Ramelteon
Recruiting
Phase 4
Interventional Study
Delirium
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 506 (estimated)
- Sponsor
- Centennial Medical Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The overall purpose of this study is to identify a medication that might treat and/or prevent delirium in intensive care unit (ICU). Currently, there is no proven medical therapy for prevention or treatment of delirium. Ramelteon is a medication approved for insomnia. We hypothesize that ramelteon may help regulate the day/night cycle and decrease ICU delirium.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Medical or surgical ICU patient
* Ability to take oral or nasogastric tube within 48 hours of admission to ICU
* Expected ICU length of stay and life expectancy at least 48 hours
* Patient or POA capable of signing informed consent within 48 hours of ICU admission
Exclusion C…
Contacts